JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Activity Details


554 * Wed, 8/1/2012, 2:00 PM - 3:50 PM CC-Room 23A
Drug Combination Studies: From Discovery to Clinical — Topic Contributed Papers
Biopharmaceutical Section
Organizer(s): Gregory Hather, Millennium: The Takeda Oncology Company
Chair(s): Ray Liu, Millennium: The Takeda Oncology Company
2:05 PM Nonlinear Blending: A General Approach to Synergy Assessment John J. Peterson, GlaxoSmithKline
2:25 PM A Phase I/II Clinical Trial Design for Drug Combinations Xuelin Huang, MD Anderson Cancer Center ; Sangbum Choi, MD Anderson Cancer Center
2:45 PM Codevelopment of Two Unmarketed Investigational Drugs: FDA Guidance and Experiences Wen Zeng, FDA ; Greg (Guoxing) Soon, FDA
3:05 PM Experimental Design for In Vitro Drug Combination Studies Gregory Hather, Millennium: The Takeda Oncology Company ; Huaihou Chen, Columbia University ; Ray Liu, Millennium: The Takeda Oncology Company
3:25 PM Applying Parametric and Nonparametric Models to Assess Treatment Effect and Drug Synergy for Combination Therapy Maiying Kong, University of Louisville ; Jack Lee, Ph.D., MD Anderson Cancer Center
3:45 PM Floor Discussion



2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.